Información del producto
Nombre:ITI-214
Marca:Biosynth
Descripción:ITI-214 is a new drug that has been shown to have a number of potential therapeutic uses. It has been shown to inhibit locomotor activity, which may be due to its ability to inhibit the release of calcium from the sarcoplasmic reticulum. ITI-214 also inhibits cyclic nucleotide phosphodiesterases, which are enzymes that break down cyclic nucleotides and thereby regulate cellular function. This inhibition leads to an increase in intracellular levels of cAMP, leading to enhanced physiological function. ITI-214 has been shown to have anti-cancer effects in vitro and in vivo. It also enhances the efficacy of cancer treatments such as radiation therapy and chemotherapy, by inhibiting tumor growth and enhancing immune responses against cancer cells. The mechanism by which ITI-214 exerts these effects is not yet known but may be related to its ability to inhibit Ercc1, a gene associated with hereditary colon cancer susceptibility or other genes involved in DNA repair pathways.
Aviso:Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Propiedades químicas
Peso molecular:507.6 g/mol
Fórmula:C29H26FN7O
Pureza:Min. 95%
Consulta técnica sobre: ITI-214
Use el carrito para solicitar presupuestos o pedidos
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.